arginine has been researched along with vidarabine phosphate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bosanquet, AG; Daniel, PT; Dörken, B; Hummel, M; Sturm, I | 1 |
| Bogdahn, U; Dünisch, G; Löbering, HG; Martin, R; Mertens, HG; Weber, H; Zapf, J | 1 |
2 other study(ies) available for arginine and vidarabine phosphate
| Article | Year |
|---|---|
In B-CLL, the codon 72 polymorphic variants of p53 are not related to drug resistance and disease prognosis.
Topics: Aged; Antineoplastic Agents; Apoptosis; Arginine; Chlorambucil; Codon; Cyclophosphamide; DNA Mutational Analysis; Doxorubicin; Drug Resistance, Neoplasm; Female; Gamma Rays; Gene Expression Regulation, Neoplastic; Genes, p53; Homozygote; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Middle Aged; Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Polymorphism, Single-Stranded Conformational; Prognosis; Proline; Vidarabine Phosphate; Vincristine | 2005 |
Vidarabin-monophosphate, BCNU, VM26--an in vitro comparative study of active agents in the treatment of malignant human brain tumours.
Topics: Adolescent; Aged; Arabinonucleotides; Brain Neoplasms; Carmustine; Cells, Cultured; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Humans; Kinetics; Male; Middle Aged; Neoplastic Stem Cells; Podophyllotoxin; RNA, Neoplasm; Teniposide; Vidarabine Phosphate | 1987 |